| 1. |
Simó R. Neurodegeneration as an early event in diabetic retinopathy[J].Endocrinol Nutr, 2011, 58:211-213.
|
| 2. |
Villarroel M, Ciudin A, Hernández C, et al.Neurodegeneration:an early event of diabetic retinopathy[J]. World J Diabetes, 2010, 1:57-64.
|
| 3. |
Antonetti DA, Klein R, Gardner TW.Diabetic retinopathy[J].N Engl J Med, 2012, 366:1227-1239.
|
| 4. |
van Dijk HW, Verbraak FD, Kok PH, et al. Early neurodegeneration in the retina of type 2 diabetic patients[J]. Invest Ophthalmol Vis Sci, 2012, 53:2715-2719.
|
| 5. |
Barber AJ, Lieth E, Khin SA, et al.Neural apoptosis in the retina during experimental and human diabetes:early onset and effect of insulin[J]. J Clin Invest, 1998, 102:783-791.
|
| 6. |
Kern TS, Barber AJ.Retinal ganglion cells in diabetes[J].J Physiol, 2008, 586:4401-4408.
|
| 7. |
Park SH, Park JW, Park SJ, et al.Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina[J].Diabetologia, 2003, 46:1260-1268.
|
| 8. |
Kern TS, Du Y, Miller CM, et al.Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy[J]. Am J Pathol, 2010, 176:2550-2558.
|
| 9. |
Valverde AM, Miranda S, Garcia-Ramirez M, et al. Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy[J]. Mol Vis, 2013, 19:47-53.
|
| 10. |
Ola MS, Nawaz MI, Siddiquei MM, et al.Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy[J].J Diabetes Complications, 2012, 26:56-64.
|
| 11. |
Sakai H, Tani Y, Shirasawa E, et al.Development of electroretinographic alterations in streptozotocin-induced diabetes in rats[J].Ophthalmic Res, 1995, 27:57-63.
|
| 12. |
Hancock HA, Kraft TW.Oscillatory potential analysis and ERGs of normal and diabetic rats[J].Invest Ophthalmol Vis Sci, 2004, 45:1002-1008.
|
| 13. |
Kizawa J, Machida S, Kobayashi T, et al.Changes of oscillatory potentials and photopic negative response in patients with early diabetic retinopathy[J].Jpn J Ophthalmol, 2006, 50:367-373.
|
| 14. |
Rolo AP, Palmeira CM. Diabetes and mitochondrial function:role of hyperglycemia and oxidative stress[J]. Toxicol Appl Pharmacol, 2006, 212:167-178.
|
| 15. |
Ola MS, Hosoya K, LaNoue KF. Regulation of glutamate metabolism by hydrocortisone and branched chain keto acids in cultured rat retinal Müller cells (TR-MUL)[J].Neurochem Int, 2011, 59:656-663.
|
| 16. |
Lau JC, Kroes RA, Moskal JR, et al.Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina[J].Mol Vis, 2013, 19:1538-1553.
|
| 17. |
Ng YK, Zeng XX, Ling EA.Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats[J].Brain Res, 2004, 1018:66-72.
|
| 18. |
Valverde AM, Miranda S, Garcia-Ramirez M, et al.Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy[J].Mol Vis, 2013, 19:47-53.
|
| 19. |
Ola MS, Nawaz MI, El-Asrar AA, et al.Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats[J].Cell Mol Neurobiol, 2013, 33:359-367.
|
| 20. |
Gaucher D, Chiappore JA, Paques M, et al.Microglial changes occur without neural cell death in diabetic retinopathy[J].Vision Res, 2007, 47:612-623.
|
| 21. |
Kniep EM, Roehlecke C, Ozkucur N, et al.Inhibition of apoptosis and reduction of intracellular pH decrease in retinal neural cell cultures by a blocker of carbonic anhydrase[J].Invest Ophthalmol Vis Sci, 2006, 47:1185-1192.
|
| 22. |
Gaspar JM, Martins A, Cruz R, et al.Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose[J].Neuroscience, 2013, 253:380-388.
|
| 23. |
Weber M, Bonaventure N, Sahel JA.Protective role of excitatory amino acid antagonists in experimental retinal ischemia[J]. Graefe's Arch Clin Exp Ophthalmol, 1995, 233:360-365.
|
| 24. |
Vorwerk CK, Lipton SA, Zurakowski D, et al.Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine[J].Invest Ophthalmol Vis Sci, 1996, 37:1618-1624.
|
| 25. |
Ha Y, Dun Y, Thangaraju M, et al. Sigma receptor 1 modulates endoplasmic reticulum stress in retinal neurons[J].Invest Ophthalmol Vis Sci, 2011, 52:527-540.
|
| 26. |
Santos JM, Mohammad G, Zhong Q, et al.Diabetic retinopathy, superoxide damage and antioxidants[J]. Curr Pharm Biotechnol, 2011, 12:352-361.
|
| 27. |
Zuo ZF, Zhang Q, Liu XZ.Protective effects of curcumin on retinal Müller cell in early diabetic rats[J].Int J Ophthalmol, 2013, 6:422-424.
|
| 28. |
Ola MS, Ahmed MM, Abuohashish HM, et al.Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats[J].Neurochem Res, 2013, 38:1572-1579.
|
| 29. |
Whitmire W, Al-Gayyar MM, Abdelsaid M, et al.Alteration of growth factors and neuronal death in diabetic retinopathy:what we have learned so far[J].Mol Vis, 2011, 17:300-308.
|
| 30. |
Ola MS, Nawaz MI, El-Asrar AA, et al. Reduced levels of brain derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and in the retina of diabetic rats[J]. Cell Mol Neurobiol, 2013, 33:359-367.
|
| 31. |
Seki M, Tanaka T, Nawa H, et al.Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats:therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells[J].Diabetes, 2004, 53:2412-2419.
|
| 32. |
Zhang J, Wu Y, Jin Y, et al. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes[J].Invest Ophthalmol Vis Sci, 2008, 49:732-742.
|
| 33. |
Wang Q, Gorbey S, Pfister F, et al.Long-term treatment with suberythropoietic Epo is vaso-and neuroprotective in experimental diabetic retinopathy[J].Cell Physiol Biochem, 2011, 27:769-782.
|
| 34. |
Chen J, Connor KM, Aderman CM, et al.Erythropoietin deficiency decreases vascular stability in mice[J]. J Clin Invest, 2008, 118:526-533.
|
| 35. |
McVicar CM, Hamilton R, Colhoun LM, et al.Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy[J].Diabetes, 2011, 60:2995-3005.
|
| 36. |
Zachary I.Neuroprotective role of vascular endothelial growth factor:signalling mechanisms, biological function, and therapeutic potential[J].Neurosignals, 2005, 14:207-221.
|
| 37. |
Nishijima K, Ng YS, Zhong L, et al.Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury[J]. Am J Pathol, 2007, 171:53-67.
|
| 38. |
何远东, 王玉, 彭江, 等.人脐带间充质干细胞中神经营养因子的表达[J].中华神经医学杂志, 2012, 11:438-442.
|
| 39. |
Xu W, Xu GX. Mesenchymal stem cells for retinal diseases[J]. Int J Ophthalmol, 2011, 4:413-421.
|
| 40. |
Yang Z, Li K, Yan X, et al. Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats[J].Graefe's Arch Clin Exp Ophthalmol, 2010, 248:1415-1422.
|
| 41. |
Scalinci SZ, Scorolli L, Corradetti G, et al.Potential role of intravitreal human placental stem cell implants in inhibiting progression of diabetic retinopathy in type 2 diabetes:neuroprotective growth factors in the vitreous[J]. Clin Ophthalmol, 2011, 5:691-696.
|
| 42. |
Mottaghi S, Larijani B, Sharifi AM.Atorvastatin:an efficient step forward in mesenchymal stem cell therapy of diabetic retinopathy[J].Cytotherapy, 2013, 15:263-266.
|
| 43. |
Brownlee M.Biochemistry and molecular cell biology of diabetic complications[J].Nature, 2001, 414:813-820.
|
| 44. |
Simo R, Hernandez C.Neurodegeneration is an early event in diabetic retinopathy:therapeutic implications[J].Br J Ophthalmol, 2012, 96:1285-1290.
|
| 45. |
Ezquer F, Ezquer M, Arango-Rodriguez M, et al.Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?[J].Acta Ophthalmol, 2014, 92:86-95.
|
